chymosin has been researched along with valsartan in 1 studies
| Studies (chymosin) | Trials (chymosin) | Recent Studies (post-2010) (chymosin) | Studies (valsartan) | Trials (valsartan) | Recent Studies (post-2010) (valsartan) |
|---|---|---|---|---|---|
| 1,018 | 6 | 258 | 3,577 | 871 | 2,140 |
| Protein | Taxonomy | chymosin (IC50) | valsartan (IC50) |
|---|---|---|---|
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0027 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0023 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0074 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binger, KJ; Campbell, DJ; Cooper, ME; Fletcher, EL; Hatzopoulos, KM; Heine, R; Miller, AG; Tan, G; Wilkinson-Berka, JL | 1 |
1 other study(ies) available for chymosin and valsartan
| Article | Year |
|---|---|
RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina.
Topics: Animals; Animals, Newborn; Cell Survival; Chymosin; Disease Models, Animal; Enzyme Precursors; Neovascularization, Physiologic; Neuroglia; Neurons; Oligopeptides; Probability; Prorenin Receptor; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Reference Values; Retina; Retinal Diseases; Retinal Vessels; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2010 |